Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

11301-11310 of 13286 results

Catalogue Number:

YP938013

Category:

A

Anti-pan-Aflatoxin Recombinant Antibody (SAA0544)

Target: pan-Aflatoxin
Target Alias Names: AFM1, AFB1, AFB2, AFG1, AFG2, Aflatoxin M1, 4-Hydroxyaflatoxin B1, Aflatoxin B1, Aflatoxin G1, Aflatoxin G2, Aflatoxin B2, Aflatoxin
Species Reactivity: Other
Other Species Reactivity: General
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG2a
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK800123

Category:

A

Anti-pan-coronavirus neutralization Recombinant Antibody (76E1)

Target: Spike
Target Alias Names: Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S
Species Reactivity: Other
Other Species Reactivity: SARS-CoV, SARS-CoV-2, MERS-CoV, HCoV-229E, HCoV-OC43, HCoV-NL63
Applications: ELISA, Other
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, lambda
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK059033

Category:

A

Anti-pan-Ebola virus Nucleoprotein Nanobody (SAA3007)

Target: Nucleoprotein
Target Alias Name: Nucleoprotein
Species Reactivity: Other
Other Species Reactivity: Bundibugyo virus (BDBV), Reston ebolavirus (REBOV) (Reston Ebola virus), Sudan ebolavirus (SEBOV) (Sudan Ebola virus), Tai Forest ebolavirus (TAFV) (Cote d'Ivoire Ebola virus), Zaire ebolavirus (ZEBOV) (Zaire Ebola virus)
Applications: ELISA, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: VHH-His
Host Species: Camelid
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK623116

Category:

A

Anti-pan-Ebolavirus GP/Envelope glycoprotein Reference Antibody (ADI-15742, RUO)

Target: GP/Glycoprotein
Target Alias Names: Envelope glycoprotein, GP1, 2, GP, Shed GP, GP1, 2-delta, GP1, GP2, GP
Species Reactivity: Other
Other Species Reactivity: Zaire ebolavirus (ZEBOV), Bundibugyo virus (BDBV), Sudan virus (SUDV), Tai Forest virus (TAFV), Reston virus (RESTV)
Applications: ELISA, Flow Cytometry, Other
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK125013

Category:

A

Anti-pan-Filovirus GP/Envelope glycoprotein Recombinant Antibody (m21D10)

Target: GP/Envelope glycoprotein
Target Alias Names: RecName: Full=Envelope glycoprotein, AltName: Full=GP1, 2, Short=GP, Contains: RecName: Full=Shed GP, AltName: Full=GP1, 2-delta, Contains: RecName: Full=GP1, Contains: RecName: Full=GP2, Flags: Precursor, GP, GP1, 2, /evidence=ECO:0000255., Filovirus glycoprotein, pfam01611, Envelope glycoprotein. /id=PRO_0000037485., Extracellular. /evidence=ECO:0000255., Shed GP. /id=PRO_0000445686., GP1. /id=PRO_0000037486., /evidence=ECO:0007829, PDB:6HS4., N->D: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., Interchain (between GP1 and GP2 chains). /evidence=ECO:0000269, PubMed:12438572., /evidence=ECO:0007829, PDB:6QD7., C->G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., Receptor-binding. /evidence=ECO:0000255., D->A: 80% loss of virus capability to enter into host cell., D->E, K: No effect on viral entry., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., L->A: Complete loss of virus capability to enter into host cell., L->F, I, K: 90% loss of virus capability to enter into host cell., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., L->A: 90% loss of virus capability to enter into host cell., L->F: Almost complete loss of virus capability to enter into host cell., L->K: Complete loss of virus capability to enter into host cell., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., R->A, E: Complete loss of virus capability to enter into host cell., R->K: No loss of virus capability to enter into host cell., S -> P (in strain: Isolate mouse-adapted)., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., F->A, E: Complete loss of virus capability to enter into host cell., F->A: About 50% loss of ability to counteract host BST2. /evidence=ECO:0000269, PubMed:27707924., F->I: No loss of virus capability to enter into host cell., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., K->A, E: 80% loss of virus capability to enter into host cell., K->R: 20% loss of virus capability to enter into host cell., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0000255., C->G: Almost complete loss of expression of GP1 and GP2. Almost complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., L->A: About 60% loss of ability to counteract host BST2. /evidence=ECO:0000269, PubMed:27707924., /evidence=ECO:0007829, PDB:9BSV., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0000255., C->G: Reduced levels of expression of GP1 and GP2. 50% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., L->A: About 60% loss of ability to counteract host BST2. /evidence=ECO:0000269, PubMed:27707924., /evidence=ECO:0007829, PDB:6HS4., C->S: Almost complete loss of expression of GP1 and GP2. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., C->S: Reduced levels of expression of GP1 and GP2. Almost complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., I->A: 90% loss of virus capability to enter into host cell., I->E: Complete loss of virus capability to enter into host cell., I->F: 50% loss of virus capability to enter into host cell., Involved in receptor recognition and/or post-binding events. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:7JPI., /evidence=ECO:0007829, PDB:7JPI., N->D: No effect on GP1 and GP2 expression. No loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., N->Y: No effect on GP1 and GP2 expression. 12% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., S -> P (in strain: Isolate mouse-adapted)., /evidence=ECO:0007829, PDB:6HS4., N->D: No effect on GP1 and GP2 expression. 12% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., N->D: No effect on GP1 and GP2 expression. 18% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:7TN9., Mucin-like region., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:7LYD., Disordered. /evidence=ECO:0000256, SAM:MobiDB-lite., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., invasion associated endopeptidase, N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Disordered. /evidence=ECO:0000256, SAM:MobiDB-lite., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Disordered. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Low complexity. /evidence=ECO:0000256, SAM:MobiDB-lite., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., RRTRR->AGTAA: Almost complete loss of cleavage between GP1 and GP2. No loss of infectivity. /evidence=ECO:0000269, PubMed:11152533., RTRR->ATAA: No effect on cleavage between GP1 and GP2. /evidence=ECO:0000269, PubMed:9882347., Cleavage, by host furin. /evidence=ECO:0000269, PubMed:9576958., GP2. /id=PRO_0000037487., /evidence=ECO:0000255., C->G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:8DPM., Fusion peptide. /evidence=ECO:0000305., /evidence=ECO:0007829, PDB:6HS4., G->R: Reduced infectivity. /evidence=ECO:0000269, PubMed:10482652., L->A, R: Reduced infectivity. /evidence=ECO:0000269, PubMed:10482652., I->A: Reduced infectivity. /evidence=ECO:0000269, PubMed:10482652., I->R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. /evidence=ECO:0000269, PubMed:10482652., /evidence=ECO:0007829, PDB:6HS4., F->A: Reduced infectivity. /evidence=ECO:0000269, PubMed:10482652., F->R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. /evidence=ECO:0000269, PubMed:10482652., G->A: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. /evidence=ECO:0000269, PubMed:10482652., P->R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. /evidence=ECO:0000269, PubMed:10482652., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0007829, PDB:6HS4., I -> T., /evidence=ECO:0007829, PDB:6HS4., /evidence=ECO:0000255., C->S: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., heptad repeat 1-heptad repeat 2 region of the transmembrane subunit of Filoviridae viruses, Ebola virus and Marburg virus, and related domains, cd09850, homotrimer interface [polypeptide binding], HR1-GP1 interface [polypeptide binding], HR1A, /evidence=ECO:0007829, PDB:2EBO., N->D: Reduced levels of expression of GP, GP1 and GP2. 20% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., HR1B, HR1C, HR1D, Cl binding site [ion binding], immunosuppressive region, /evidence=ECO:0007829, PDB:2EBO., /evidence=ECO:0007829, PDB:2EBO., /evidence=ECO:0000269, PubMed:12438572., CX(6, 7)C motif, C->S: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., /evidence=ECO:0007829, PDB:2EBO., C->G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., C->G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:2EBO., HR2, N->D: Slightly reduced levels of expression of GP1 and GP2. No loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:12438572., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., D->V: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., K->R, V: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., T->I: 50% loss of release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., L->V: 60% loss of release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., L->V: Increased GP shedding. /evidence=ECO:0000269, PubMed:26092855., P->A: 60% loss of release of soluble GP1, 2delta., Cleavage, by host ADAM17. /evidence=ECO:0000269, PubMed:15103332., D->E: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., D->L, V: Increased release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., D->V: Decreased GP shedding. /evidence=ECO:0000269, PubMed:26092855., Q->V: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., G->V: 40% loss of release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., D->V: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., N->A: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., D->V: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., N->A: No effect on release of soluble GP1, 2delta. /evidence=ECO:0000269, PubMed:15103332., Helical. /evidence=ECO:0000255., Important role for host BST2/tetherin antagonism. /evidence=ECO:0000269, PubMed:27707924., G->L: About 60% loss of viral release, when associated with L-664. /evidence=ECO:0000269, PubMed:29669839., A->L: About 60% loss of viral release, when associated with L-660. /evidence=ECO:0000269, PubMed:29669839., C->A: Reduced palmitoylation. No effect on GP processing and association with retrovirus particle. No loss of virus capability to enter into host cell. Loss of localization to the rafts, when associated with A-670. /evidence=ECO:0000269, PubMed:11152533, ECO:0000269, PubMed:11877482, ECO:0000269, PubMed:12438572., C->F: Slightly reduced levels of expression of GP1 and GP2. Greatly reduced GP processing and association with retrovirus particle. 43% loss of virus capability to enter into host cell. Loss of localization to the rafts, when associated with A-672. /evidence=ECO:0000269, PubMed:11152533, ECO:0000269, PubMed:11877482, ECO:0000269, PubMed:12438572., S-palmitoyl cysteine, by host. /evidence=ECO:0000269, PubMed:11152533., Cytoplasmic. /evidence=ECO:0000255., C->A: Reduced palmitoylation. No effect on GP processing and association with retrovirus particle. No loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:11152533, ECO:0000269, PubMed:12438572., C->F: Slightly reduced levels of expression of GP1 and GP2. Almost no effect on GP processing and association with retrovirus particle. 24% loss of virus capability to enter into host cell. /evidence=ECO:0000269, PubMed:11152533, ECO:0000269, PubMed:12438572., S-palmitoyl cysteine, by host. /evidence=ECO:0000269, PubMed:11152533., Nucleocapsid protein, Protein N, Nucleoprotein. /id=PRO_0000222174., Ebola nucleoprotein, pfam05505, /evidence=ECO:0000255., Disordered. /evidence=ECO:0000256, SAM:MobiDB-lite., Acidic residues. /evidence=ECO:0000256, SAM:MobiDB-lite., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., Acidic residues. /evidence=ECO:0000256, SAM:MobiDB-lite., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., /evidence=ECO:0007829, PDB:6U55., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U55., /evidence=ECO:0007829, PDB:6U55., /evidence=ECO:0007829, PDB:6U55., /evidence=ECO:0007829, PDB:6U55., /evidence=ECO:0007829, PDB:6U52., /evidence=ECO:0007829, PDB:6U52., GP1, 2, Virion spike glycoprotein, Filovirus glycoprotein, pfam01611, /evidence=ECO:0000250., Envelope glycoprotein. /evidence=ECO:0000250. /id=PRO_0000314986., Extracellular. /evidence=ECO:0000255., GP1. /evidence=ECO:0000250. /id=PRO_0000314987., Receptor-binding. /evidence=ECO:0000250., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6BP2., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Disordered. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., Mucin-like region. /evidence=ECO:0000250., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Low complexity. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Polar residues. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Low complexity. /evidence=ECO:0000256, SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Cleavage, by host furin. /evidence=ECO:0000250., GP2. /evidence=ECO:0000250. /id=PRO_0000314988., /evidence=ECO:0007829, PDB:6BP2., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., Fusion peptide. /evidence=ECO:0000250., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., /evidence=ECO:0007829, PDB:6BP2., heptad repeat 1-heptad repeat 2 region of the transmembrane subunit of Filoviridae viruses, Ebola virus and Marburg virus, and related domains, cd09850, homotrimer interface [polypeptide binding], HR1-GP1 interface [polypeptide binding], HR1A, N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., HR1B, HR1C, HR1D, Cl binding site [ion binding], immunosuppressive region, /evidence=ECO:0007829, PDB:6BP2., CX(6, 7)C motif, /evidence=ECO:0007829, PDB:6BP2., HR2, N-linked (GlcNAc...) asparagine, by host. /evidence=ECO:0000255., Helical. /evidence=ECO:0000255., Cytoplasmic. /evidence=ECO:0000255., S-palmitoyl cysteine, by host. /evidence=ECO:0000250, UniProtKB:P35253., S-palmitoyl cysteine, by host. /evidence=ECO:0000250, UniProtKB:P35253.
Species Reactivity: Other
Other Species Reactivity: Zaire Ebola virus (ZEBOV), Sudan Ebolavirus (SEBOV/SUDV), Marburg virus (MARV)
Applications: ELISA, Western Blot
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, kappa
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

HW310063

Category:

A

Anti-pan-Glypican Recombinant Antibody (HS20)

Target: pan-Glypican
Target Alias Names: pan-Glypican, heparan sulfate, Glypican-1, Secreted glypican-1, GPC1, Glypican-2, Secreted glypican-2, GPC2, Glypican-3, GTR2-2, Intestinal protein OCI-5, MXR7, Glypican-3 alpha subunit, Glypican-3 beta subunit, GPC3, OCI5, Glypican-4, K-glypican, Secreted glypican-4, GPC4, Glypican-5, Secreted glypican-5, GPC5, Glypican-6, Secreted glypican-6, GPC6
Species Reactivity: Human
Applications: ELISA, Flow Cytometry, Other
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, kappa
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK127023

Category:

A

Anti-pan-IBDV VP2 Recombinant Antibody (SAA2669)

Target: VP2
Target Alias Names: Precursor of VP2 (Pre-VP2), Capsid protein VP2, VP2
Species Reactivity: Other
Other Species Reactivity: Avian infectious bursal disease virus (IBDV) (Gumboro disease virus)
Applications: ELISA, Immunoprecipitation
Type: Primary Recombinant
Isotypes/Mimetics: IgG2a, lambda
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

HX973033

Category:

A

Anti-pan-MAGUK Recombinant Antibody (K28/86)

Target: MAGUK
Target Alias Names: PSD-95, PSD95, Disks large homolog 4, Synapse-associated protein 90, DLG4, Postsynaptic density protein 95, SAP-90, SAP90
Species Reactivity: Human, Mouse, Rat
Applications: Immunocytochemistry, Immunoprecipitation, Western Blot
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, kappa
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

YP952023

Category:

A

Anti-Pan-pS(pSer)/pT(pThr) Recombinant Antibody (SAA0308)

Target: pSer/pThr
Target Alias Name: Pan-pS(pSer)/pT(pThr)
Species Reactivity: Other
Other Species Reactivity: Broad-Spectrum
Applications: ELISA, Western Blot, Other
Type: Primary Recombinant
Isotypes/Mimetics: IgG2a, kappa
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

YP952013

Category:

A

Anti-Pan-pS/pSer/Phosphoserine Recombinant Antibody (SAA0307)

Target: Pan-Phosphoserine/pSer
Target Alias Names: Pan-pS, pSer, Phosphoserine
Species Reactivity: Other
Other Species Reactivity: Broad-Spectrum
Applications: ELISA, Western Blot, Other
Type: Primary Recombinant
Isotypes/Mimetics: IgG2a, kappa
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression